Literature DB >> 17466644

Beyond hip: importance of other nonspinal fractures.

P D Delmas1, F Marin, R Marcus, D A Misurski, B H Mitlak.   

Abstract

It is widely accepted that hip and spine fractures are associated with substantial morbidity, but there is growing awareness that other fractures are under-recognized. The incidence of nonspinal, nonhip fractures is higher than for hip fractures because they occur at an earlier age. Furthermore, the incidence of nonspinal, nonhip fractures exceeds that of hip fractures in men and women >80 years old. Nonspinal, nonhip fractures are associated with considerable morbidity. On average, women with humeral, ankle, distal forearm, and foot fractures experience substantial numbers of limited activity days, and nonspinal, nonhip fractures account for almost a third of health care expenditures attributable to osteoporotic fractures. Nonspinal, nonhip fractures are associated with low bone mineral density, thus it may be possible to identify those at risk. Because these fractures also are indicative of increased risk at other sites, those susceptible might benefit from assessments including these other fracture types. It is the clinician's responsibility to attend to and recognize that nonspinal, nonhip fractures are usually associated with osteoporosis and should be treated.

Entities:  

Mesh:

Year:  2007        PMID: 17466644     DOI: 10.1016/j.amjmed.2006.06.003

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  21 in total

Review 1.  Osteoporosis and the orthopaedic surgeon: basic concepts for successful co-management of patients' bone health.

Authors:  Ryan P Farmer; Benoit Herbert; Derly O Cuellar; Jiandong Hao; Philip F Stahel; Robin Yasui; David J Hak; Cyril Mauffrey
Journal:  Int Orthop       Date:  2014-03-21       Impact factor: 3.075

2.  Prevalence of osteoporosis and fractures among women prescribed osteoporosis medication in five European countries: the POSSIBLE EU study.

Authors:  C Roux; C Cooper; A Díez-Pérez; L Martinez; S Ortolani; M Gitlin; G Möller; S Shepherd; N Freemantle
Journal:  Osteoporos Int       Date:  2010-07-14       Impact factor: 4.507

3.  Prior ankle fractures in postmenopausal women are associated with low areal bone mineral density and bone microstructure alterations.

Authors:  E Biver; C Durosier; T Chevalley; F R Herrmann; S Ferrari; R Rizzoli
Journal:  Osteoporos Int       Date:  2015-04-08       Impact factor: 4.507

Review 4.  Physical Activity for Strengthening Fracture Prone Regions of the Proximal Femur.

Authors:  Robyn K Fuchs; Mariana E Kersh; Julio Carballido-Gamio; William R Thompson; Joyce H Keyak; Stuart J Warden
Journal:  Curr Osteoporos Rep       Date:  2017-02       Impact factor: 5.096

5.  Are young women and men with rheumatoid arthritis at risk for fragility fractures? A population-based study.

Authors:  Shreyasee Amin; Sherine E Gabriel; Sara J Achenbach; Elizabeth J Atkinson; L Joseph Melton
Journal:  J Rheumatol       Date:  2013-08-15       Impact factor: 4.666

6.  Trends in fracture incidence: a population-based study over 20 years.

Authors:  Shreyasee Amin; Sara J Achenbach; Elizabeth J Atkinson; Sundeep Khosla; L Joseph Melton
Journal:  J Bone Miner Res       Date:  2014-03       Impact factor: 6.741

Review 7.  Osteoporosis in men.

Authors:  Sundeep Khosla; Shreyasee Amin; Eric Orwoll
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

8.  Declining incidence of low-trauma knee fractures in elderly women: nationwide statistics in Finland between 1970 and 2006.

Authors:  P Kannus; S Niemi; J Parkkari; H Sievänen; M Palvanen
Journal:  Osteoporos Int       Date:  2008-05-14       Impact factor: 4.507

9.  Updated fracture incidence rates for the US version of FRAX.

Authors:  B Ettinger; D M Black; B Dawson-Hughes; A R Pressman; L J Melton
Journal:  Osteoporos Int       Date:  2009-08-25       Impact factor: 4.507

Review 10.  Teriparatide in the management of osteoporosis.

Authors:  Donald Bodenner; Carolyn Redman; Ann Riggs
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.